Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
New strategy to stop melanoma spread
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help…
Novel molecules display potent and selective action against ovarian tumour cells
A group led by a researcher affiliated with the University of São Paulo’s São Carlos…
Initiative helps increase breast cancer screening
A new study has found that using a community-codesign approach can massively increase mammography screening…
SABCS 2018: Adjuvant capecitabine did not significantly improve outcomes for patients with early-stage triple-negative breast cancer
- SABCS 2018: Adjuvant chemotherapy might not add benefit in breast cancer patients who have excellent response to neoadjuvant chemotherapy
- SABCS 2018: Phase III KATHERINE clinical trial crossed early reporting boundary and met its primary endpoint
- SABCS 2018: Delaying adjuvant chemotherapy associated with worse outcomes for patients with triple-negative breast cancer
Countries with high stomach cancer burden need to do more to prevent the disease
A new report from the International Agency for Research on Cancer (IARC), the specialised cancer agency of the World Health…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.